Activist investor Starboard Value has taken a sizeable stake in Kenvue Inc., the maker of Tylenol and Listerine, and is seeking changes, according to reports Sunday night. The Wall Street Journal ...

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job. Starboard has called on Pfizer’s board to “hold management ...

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has Johnson & Johnson’s consumer health spinout Kenvue in its sights.

Activist investor Starboard Value has launched a broadside against Pfizer's leadership under chief executive Albert Bourla, claiming at least $20 billion in value – and possibly as much as $60 ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. This data feed is not available at this time.

Activist investor Starboard Value could push for Kenvue (NYSE:KVUE) to divest some/all of its "challenged" skin, healthcare and beauty division after a report that the investor has accumulated a ...

Activist investor Starboard Value has sharpened its criticism of Pfizer Inc. (NYSE:PFE), holding the pharmaceutical giant’s management accountable for failing to deliver on its promises of ...

Oct 20 (Reuters) - Hedge fund Starboard Value has taken a stake in Kenvue (KVUE.N), opens new tab, the consumer products company that makes Band-Aid, Listerine, and Tylenol, and which went public ...

A young Finnish company specializing in hydrodynamic electric watercraft called Foil.One has introduced its flagship product, and it looks cool as hell. The Pegasus is a single-seat electric ...

At an investor summit in New York on Tuesday, activist investor Starboard called out Pfizer's PFE board of directors to take action against the latter’s management for making poor capital ...

NEW YORK, Oct 22 (Reuters) - Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's (PFE.N), opens new tab board needs to hold management accountable ...